24.51

24.51 (0.05%)

As of Jan 14, 2022

Aadi Bioscience, Inc. [AADI]

Source: 

Company Overview

Aadi Bioscience, Inc. is a biopharmaceutical company focused on developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Our lead drug product, FYARRO  , is a form of sirolimus bound to albumin. Sirolimus is a potent inhibitor of the mTOR biological pathway, the activation of which pathway can promote tumor growth.

CountryUS
Headquarterspacific palisadescalifornia
Phone Number(424) 473-8055
Industrypharmaceutical preparations
CEOScott Giacobello
Websitewww.aadibio.com